Genedrive Stock

Genedrive EBIT

The EBIT of Genedrive (GDR.L) as of Aug 14, 2026 is -5.38 M GBP. In the previous year, EBIT was -5.31 M GBP — a change of 1.28% (lower).

EBIT

-5.38 MGBP

YoY

1.28%

Last updated:

In 2026, Genedrive's EBIT was -5.38 M GBP, a 1.28% increase from the -5.31 M GBP EBIT recorded in the previous year.

The Genedrive EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (k GBP)
Date
EBIT (k GBP)
Jan 1, 2018
-5,264.00 base
Jan 1, 2019
-4,449.00 base
Jan 1, 2020
-5,640.00 base
Jan 1, 2021
-5,482.00 base
Jan 1, 2022
-5,615.00 base
Jan 1, 2023
-5,224.00 base
Jan 1, 2024
-5,312.00 base
Jan 1, 2025
-5,380.00 base
YEAREBIT (k GBP)
2025 -5,380.00
2024 -5,312.00
2023 -5,224.00
2022 -5,615.00
2021 -5,482.00
2020 -5,640.00
2019 -4,449.00
2018 -5,264.00
2017 -5,004.00
2016 -5,426.00
2015 -4,040.00
2014 -2,300.00
2013 -1,520.00
2012 -840.00
2011 390.00
2010 310.00
2009 -700.00
2008 -1,450.00
2007 -1,240.00
2006 -800.00
Access this data via the Eulerpool API

Genedrive Revenue

Genedrive Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
1.94 M GBP
-5.26 M GBP
-5.97 M GBP
Jan 1, 2019
2.36 M GBP
-4.45 M GBP
-3.64 M GBP
Jan 1, 2020
1.06 M GBP
-5.64 M GBP
-19.42 M GBP
Jan 1, 2021
687,000.00 GBP
-5.48 M GBP
-691,000.00 GBP
Jan 1, 2022
49,000.00 GBP
-5.62 M GBP
-4.68 M GBP
Jan 1, 2023
55,000.00 GBP
-5.22 M GBP
-5.15 M GBP
Jan 1, 2024
501,000.00 GBP
-5.31 M GBP
-7.08 M GBP
Jan 1, 2025
954,000.00 GBP
-5.38 M GBP
-5.23 M GBP

Genedrive Margins

Genedrive stock margins

The Genedrive margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Genedrive. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Genedrive.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
35.12 %
-271.62 %
-307.89 %
Jan 1, 2019
35.12 %
-188.36 %
-153.94 %
Jan 1, 2020
35.12 %
-532.58 %
-1,833.71 %
Jan 1, 2021
35.12 %
-797.96 %
-100.58 %
Jan 1, 2022
35.12 %
-11,459.18 %
-9,540.82 %
Jan 1, 2023
35.12 %
-9,498.18 %
-9,363.64 %
Jan 1, 2024
35.12 %
-1,060.28 %
-1,412.18 %
Jan 1, 2025
35.12 %
-563.94 %
-548.32 %

Genedrive Stock analysis

What does Genedrive do? Genedrive PLC is a biomedical company based in Manchester, United Kingdom, specializing in the development of innovative diagnostic tests for infectious diseases and cancer. The company was founded in 2007 under the name Epistem Limited and went public in 2013. The business model of Genedrive involves developing and distributing innovative molecular diagnostic tests for diseases worldwide. The company's main goal is to change the way infectious diseases and cancer are diagnosed and treated by offering rapid, accurate, and cost-effective tests. The company has two main divisions: Genprobe and Instruments. Under Genprobe, various in vitro diagnostic tests for infectious diseases and diseases of the human immune system, including tuberculosis, hepatitis C, hepatitis B, HIV, and others, are offered. Under Instruments, Genedrive offers PCR instruments used for analyzing samples for DNA and RNA sequences. Some of Genedrive's key products include: - Genedrive HCV-ID Testkit: A test kit for identifying and quantifying hepatitis C viruses (HCV) in human blood samples. The test provides results within 90 minutes and has high accuracy. - Genedrive MT-RNR1 Testkit: A test kit for the rapid diagnosis of tuberculosis (TB), one of the most common infectious diseases worldwide. The test utilizes PCR technology and provides results within 90 minutes. - Genedrive Genedrive 96: An instrument for simultaneous analysis of up to 96 PCR samples. The system offers high accuracy and precision in analyzing RNA and DNA sequences. The company collaborates closely with leading research institutions and health organizations worldwide to improve its products and develop new tests. Genedrive has formed partnerships with the British government, the US Department of Defense, and other institutions. In recent years, the company has made significant progress in developing new diagnostic tests for infectious diseases and cancer. For example, Genedrive recently signed an agreement with the Foundation for Innovative New Diagnostics (FIND) to develop a molecular test for the Ebola virus. The company also has a pipeline of projects, including tests for COVID-19 and antibiotic resistance. Despite Genedrive's success, the company remains committed to innovation and research in order to transform the diagnostics industry and improve the health of people worldwide. Genedrive is expected to continue playing an important role in the fight against infectious diseases and cancer in the future. Genedrive is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Genedrive's EBIT

Genedrive's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Genedrive's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Genedrive's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Genedrive’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Genedrive stock

EBIT of Genedrive is -5.38 M GBP in 2026.

EBIT of Genedrive changed from -5.31 M GBP to -5.38 M GBP, representing a 1.28% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Genedrive since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Genedrive historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Genedrive

All Key Metrics — Genedrive